Localization of galectin-3 in normal and diseased pancreatic tissue

[1]  J. Hirabayashi,et al.  Galectins: a family of animal lectins that decipher glycocodes. , 1996, Journal of biochemistry.

[2]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[3]  H. Inohara,et al.  Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. , 1995, Cancer research.

[4]  R. Bresalier,et al.  Expression of an endogenous galactose‐binding lectin correlates with neoplastic progression in the colon , 1995, Cancer.

[5]  M. Schachner,et al.  Galectin‐3, a β‐Galactoside‐Binding Animal Lectin, Binds to Neural Recognition Molecules , 1995, Journal of neurochemistry.

[6]  C. Colnot,et al.  Galectin‐3 is expressed in the notochord, developing bones, and skin of the postimplantation mouse embryo , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  R. Lotan,et al.  Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. , 1995, Cancer research.

[8]  W. Sanger,et al.  Differences in molecular biological, biological and growth characteristics between the immortal and malignant hamster pancreatic cells. , 1995, Carcinogenesis.

[9]  E. Farias,et al.  Secretion of gelatinases by human pancreatic cancer cell lines: lack of correlation with invasive ability. , 1995, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia.

[10]  L. Liotta,et al.  Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. , 1994, Biochemistry.

[11]  H. Inohara,et al.  Identification of human melanoma cellular and secreted ligands for galectin-3. , 1994, Biochemical and Biophysical Research Communications - BBRC.

[12]  K. Jeng,et al.  The adhesive specificity of the soluble human lectin, IgE-binding protein, toward lipid-linked oligosaccharides. Presence of the blood group A, B, B-like, and H monosaccharides confers a binding activity to tetrasaccharide (lacto-N-tetraose and lacto-N-neotetraose) backbones. , 1994, Biochemistry.

[13]  R. Bresalier.  Adhesion molecules and gastrointestinal malignancies. , 1994, Gastroenterology.

[14]  Richard D. Cummings,et al.  Galectins: A family of animal β-galactoside-binding lectins , 1994, Cell.

[15]  C. J. Garrison,et al.  The endogenous lectin RL-29 is transynaptically induced in dorsal horn neurons following peripheral neuropathy in the rat , 1993, Brain Research.

[16]  E. Taylor,et al.  Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. , 1993, The Journal of biological chemistry.

[17]  Edward A. Lee,et al.  Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Rizzino,et al.  Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. , 1993, Carcinogenesis.

[19]  S. Barondes,et al.  L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. , 1993, Biochemistry.

[20]  M. Taylor,et al.  Biology of animal lectins. , 1993, Annual review of cell biology.

[21]  P. Pour,et al.  Modification of blood group A antigen expression in a pancreatic cancer cell line (PC‐1) by inhibitors of N‐glycan processing , 1992, Journal of cellular biochemistry.

[22]  E. Campo,et al.  Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. , 1992, Journal of the National Cancer Institute.

[23]  V. Steele,et al.  Development of chemopreventive agents for bladder cancer , 1992, Journal of cellular biochemistry. Supplement.

[24]  A. Mercurio,et al.  Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma. , 1991, Archives of surgery.

[25]  R. Lotan,et al.  Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. , 1991, Cancer research.

[26]  V. Hogan,et al.  Evidence for the role of 34‐kDa galactoside‐binding lectin in transformation and metastasis , 1990, International journal of cancer.

[27]  P. Pour,et al.  Comparative studies on expression of tumor-associated antigens in human and induced pancreatic cancer in syrian hamsters , 1990, International journal of pancreatology : official journal of the International Association of Pancreatology.

[28]  P. Pour,et al.  Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. , 1990, The American journal of pathology.

[29]  A. Raz,et al.  Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein. , 1989, Cancer research.

[30]  R. Metzgar,et al.  Characterization of Clones of a Human Pancreatic Adenocarcinoma Cell Line Representing Different Stages of Differentiation , 1989, Pancreas.

[31]  P. Pour,et al.  Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. , 1989, Carcinogenesis.

[32]  E. Hollande,et al.  Differentiation of the human pancreatic adenocarcinoma cell line (Capan‐1) in culture and co‐culture with fibroblasts dome formation , 1988, International journal of cancer.

[33]  P. Pour,et al.  Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. , 1988, Cancer research.

[34]  R. Lotan,et al.  Transformation‐related changes in the expression of endogenous cell lectins , 1987, International journal of cancer.

[35]  S. Barondes,et al.  Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides. , 1986, The Journal of biological chemistry.

[36]  R. Lotan,et al.  Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells. , 1986, Cancer research.

[37]  V. Schirrmacher.  Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. , 1985, Advances in cancer research.

[38]  T. Springer,et al.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. , 1982, Journal of immunology.

[39]  S. Hsu,et al.  A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. , 1981, American journal of clinical pathology.

[40]  D. Nagel,et al.  Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease , 1981, Cancer.

[41]  P. Pour,et al.  A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. , 1977, Journal of the National Cancer Institute.

[42]  J. Fogh,et al.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.

[43]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[44]  J. Fogh,et al.  New Human Tumor Cell Lines , 1975 .

[45]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.